Brimonidin[(R,r)]-Tartrat Hexal

Brimonidine Tartrate Hexal is an ophthalmic solution used to reduce intraocular pressure in conditions like glaucoma. This medication is designed for ocular use and is manufactured by Hexal AG in the EU.

Brimonidine Tartrate Hexal is primarily used to lower elevated intraocular pressure in the eyes. It is often prescribed for conditions such as open-angle glaucoma or ocular hypertension. The active ingredient, brimonidine tartrate, works by reducing the production of aqueous humor in the eyes, which helps to alleviate pressure. This medication is specifically formulated for ocular use and is not intended for other types of application.

When used as directed, Brimonidine Tartrate Hexal may cause temporary stinging or burning in the eyes. Some users might experience redness, itching, or blurred vision. These effects are generally mild and short-lived. However, if any of these symptoms persist or worsen, it is advisable to consult a healthcare professional.

Brimonidine Tartrate Hexal should be used with caution in individuals with a history of eye conditions or allergies to any of its components. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid touching the tip of the dropper to prevent contamination. Store the medication at room temperature and keep it out of reach of children.

Brimonidine Tartrate Hexal may interact with other medications, including beta-blockers and other eye drops. It is important to inform your healthcare provider about all medications you are currently taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication. Always consult a healthcare professional before starting any new medication.